AMONDYS 45
Live / Registered — Registered (as of 23 Nov 2021)
What this means for you
Registered since 23 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90135119
- Registration number
- 6570569
- Mark type
- Stylized text
- Filed
- 25 Aug 2020
- Published for opposition
- 01 Dec 2020
- Registered
- 23 Nov 2021
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders
Owner
- Sarepta Therapeutics, Inc., Cambridge, MA, US
- Sarepta Therapeutics, Inc., Cambridge, MA, US
- Sarepta Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 23 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
- 21 Oct 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Oct 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Sept 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 02 Sept 2021 — USE AMENDMENT FILED
- 14 Sept 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Sept 2021 — TEAS STATEMENT OF USE RECEIVED
- 08 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jul 2021 — SOU EXTENSION 1 GRANTED
- 06 Jul 2021 — SOU EXTENSION 1 FILED
- 06 Jul 2021 — SOU TEAS EXTENSION RECEIVED
- 26 Jan 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Dec 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Dec 2020 — PUBLISHED FOR OPPOSITION
- 11 Nov 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED